Back

Huons leads three Korean drug-development projects for eye disease and cancer

Verifying
  • Huons will lead three consortiums developing treatments for diabetic eye disease and cancer.
  • Three of 10 projects selected this year include Huons as a participating company.
  • Surginex, Pinotbio and PearlsInMires are Huons’ respective biotech partners.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.